Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.a

Path: NSIP-cellular pattern (see also Ia, Ib)

Publications

Tomioka R, King TE

Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.

American journal of respiratory and critical care medicine 1997 Mar;155;1011-20 — 1997 Mar — 1011-20

Blackwell TS, Gossage JR

Gold pulmonary toxicity in a patient with a normal chest radiograph.

Southern medical journal 1995 Jun;88;644-6 — 1995 Jun — 644-6

James DW, Whimster WF, Hamilton EB

Gold lung.

British medical journal 1978 Jun 10;1;1523-4 — 1978 Jun 10 — 1523-4

Winterbauer RH, Wilske KR, Wheelis RF

Diffuse pulmonary injury associated with gold treatment.

The New England journal of medicine 1976 Apr 22;294;919-21 — 1976 Apr 22 — 919-21